Inhibitory effect of flavonoids on the efflux of N -acetyl 5-aminosalicylic acid intracellularly formed in caco-2 cells

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Koji, Furuno ^a   Shin, Yoshimura ^a   Kentaro, Kawano ^a   Ryusuke, Matsumura ^a   Narumi, Sugihara ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYFLAVONE; 3',4' DIHYDROXYFLAVONE; 5 ACETAMIDOSALICYLIC ACID; 7 HYDROXYFLAVONE; 7,3',4' TRIHYDROXYFLAVONE; 7,4' DIHYDROXYFLAVONE; APIGENIN; CHRYSIN; CYCLOSPORIN A; DIOSMETIN; EPICATECHIN; EPIGALLOCATECHIN; FISETIN; FLAVONOID; GALANGIN; GERALDOL; GESTONORONE CAPROATE; GLYCOPROTEIN P INHIBITOR; INDOMETACIN; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; MESALAZINE; MITOXANTRONE; MORIN; PRIMULETIN; QUERCETIN; QUINIDINE; TAXIFOLIN; UNCLASSIFIED DRUG; VERLUKAST;

ARTICLE; CELL STRAIN CACO 2; CELL TRANSPORT; CONJUGATION; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; TISSUE CULTURE;

EID: 69249215244     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/467489     Document Type: Article

References (39)

1. Das K. M., Eastwood M. A., McManus J. P., Sircus W., Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype The New England Journal of Medicine 1973 289 10 491 495
2. Ardizzone S., Porro G. B., Comparative tolerability of therapies for ulcerative colitis Drug Safety 2002 25 8 561 582
3. Allgayer H., Ahnfelt N. O., Kruis W., Colonic N -acetylation of 5-aminosalicylic acid in inflammatory bowel disease Gastroenterology 1989 97 1 38 41
4. Ricart E., Taylor W. R., Loftus E. V., N -acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis American Journal of Gastroenterology 2002 97 7 1763 1768
5. Bat B., Lodowska J., Orchel A., Evaluation of biotransformation of sulphasalazine in the colon epithelial Caco-2 cells Acta Poloniae Pharmaceutica 2004 61 8 10
6. Sharon P., Ligumsky M., Rachmilewitz D., Zor U., Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine Gastroenterology 1978 75 4 638 640
7. Hawkey C. J., Truelove S. C., Inhibition of prostaglandin synthetase in human rectal mucosa Gut 1983 24 3 213 217
8. Willoughby C. P., Piris J., Truelove S. C., The effect of topical N -acetyl-5-aminosalicylic acid in ulcerative colitis Scandinavian Journal of Gastroenterology 1980 15 6 715 719
9. Layer P. H., Goebell H., Keller J., Dignass A., Klotz U., Delivery and fate of oral mesalamine microgranules within the human small intestine Gastroenterology 1995 108 5 1427 1433
10. Bondesen S., Intestinal fate of 5-aminosalicylic acid: regional and systemic kinetic studies in relation to inflammatory bowel disease Pharmacology and Toxicology 1997 81 supplement 2 1 28
11. Zhou S. Y., Fleisher D., Pao L. H., Li C., Winward B., Zimmermann E. M., Intestinal metabolism and transport of 5-aminosalicylate Drug Metabolism and Disposition 1999 27 4 479 485
12. Di Pietro A., Conseil G., Prez-Victoria J. M., Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters Cellular and Molecular Life Sciences 2002 59 2 307 322
13. Zhang S., Morris M. E., Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport Journal of Pharmacology and Experimental Therapeutics 2003 304 3 1258 1267
14. Takano M., Yumoto R., Murakami T., Expression and function of efflux drug transporters in the intestine Pharmacology and Therapeutics 2006 109 1-2 137 161
15. Leslie E. M., Mao Q., Oleschuk C. J., Deeley R. G., Cole S. P. C., Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATpase activities by interaction with dietary flavonoids Molecular Pharmacology 2001 59 5 1171 1180
16. Bobrowska-Hgerstrand M., Wrbel A., Mrwczyska L., Flavonoids as inhibitors of MRP1-like efflux activity in human erythrocytes. A structure-activity relationship study Oncology Research 2003 13 11 463 469
17. ania-Pietrzak B., Hendrich A. B., Zugaj J., Michalak K., Metabolic O-demethylation does not alter the influence of isoflavones on the biophysical properties of membranes and MRP1-like protein transport activity Archives of Biochemistry and Biophysics 2005 433 2 428 434
18. Van Zanden J. J., Wortelboer H. M., Bijlsma S., Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2 Biochemical Pharmacology 2005 69 4 699 708
19. Van Zanden J. J., De Mul A., Wortelboer H. M., Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin Biochemical Pharmacology 2005 69 11 1657 1665
20. Van Zanden J. J., van der Woude H., Vaessen J., The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential Biochemical Pharmacology 2007 74 2 345 351
21. Brendel E., Meineke I., Witsch D., Zschunke M., Simultaneous determination of 5-aminosalicylic acid and 5-acetylaminosalicylic acid by high-performance liquid chromatography Journal of Chromatography 1987 385 299 304
22. Sugihara N., Toyama K., Michihara A., Akasaki K., Tsuji H., Furuno K., Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer Toxicology 2006 223 1-2 156 165
23. Mizoyama Y., Takaki H., Sugihara N., Furuno K., Inhibitory effect of flavonoids on N -acetylation of 5-aminosalicylic acid in cultured rat hepatocytes Biological and Pharmaceutical Bulletin 2004 27 9 1455 1458
24. Walgren R. A., Karnaky K. J. Jr., Lindenmayer G. E., Walle T., Efflux of dietary flavonoid quercetin 4 ′- -glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-21 Journal of Pharmacology and Experimental Therapeutics 2000 294 3 830 836
25. Hong J., Lambert J. D., Lee S.-H., Sinko P. J., Yang C. S., Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites Biochemical and Biophysical Research Communications 2003 310 1 222 227
26. Schrickx J., Lektarau Y., Fink-Gremmels J., Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells Archives of Toxicology 2006 80 5 243 249
27. Honda Y., Ushigome F., Koyabu N., Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux British Journal of Pharmacology 2004 143 7 856 864
28. Takasuna K., Hagiwara T., Watanabe K., Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea Cancer Chemotherapy and Pharmacology 2006 58 4 494 503
29. Yanase K., Tsukahara S., Mitsuhashi J., Sugimoto Y., Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development Cancer Letters 2006 234 1 73 80
30. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., Keppler D., Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump Cancer Research 1996 56 5 988 994 (Pubitemid 26065391)
31. Konig J., Nies A. T., Cui Y., Leier I., Keppler D., Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance Biochimica et Biophysica Acta 1999 1461 2 377 394
32. Suzuki H., Sugiyama Y., Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition Advanced Drug Delivery Reviews 2002 54 1319 1331
33. Gotoh Y., Suzuki H., Kinoshita S., Hirohashi T., Kato Y., Sugiyama Y., Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats Journal of Pharmacology and Experimental Therapeutics 2000 292 1 433 439
34. Slitt A. L., Cherrington N. J., Maher J. M., Klaassen C. D., Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites Drug Metabolism and Disposition 2003 31 9 1176 1186
35. Zamek-Gliszczynski M. J., Hoffmaster K. A., Humphreys J. E., Tian X., Nezasa K.-I., Brouwer K. L. R., Differential involvement of Mrp2 (Abcc2) and Bcrp (Abcg2) in biliary excretion of 4-methylumbelliferyl glucuronide and sulfate in the rat Journal of Pharmacology and Experimental Therapeutics 2006 319 1 459 467
36. Havsteen B., Flavonoids, a class of natural products of high pharmacological potency Biochemical Pharmacology 1983 32 7 1141 1148
37. Cook N. C., Samman S., Flavonoidschemistry, metabolism, cardioprotective effects, and dietary sources Journal of Nutritional Biochemistry 1996 7 2 66 76
38. Ueno I., Nakano N., Hirono I., Metabolic fate of [ C 14 ] quercetin in the ACl rat Japanese Journal of Experimental Medicine 1983 53 1 41 50
39. Gugler R., Leschik M., Dengler H. J., Disposition of quercetin in man after single oral and intraveneous doses European Journal of Clinical Pharmacology 1975 9 229 234